Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment.

Kheirkhah Rahimabad P, Sekhon S, John E

Open source

DOI
10.1007/s10552-026-02236-y
Published
2026 Aug 25
Container
Cancer causes & control : CCC
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10552-026-02236-y,
  title = {Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment.},
  author = {Kheirkhah Rahimabad P and Sekhon S and John E},
  year = {2026},
  journal = {Cancer causes \& control : CCC},
  doi = {10.1007/s10552-026-02236-y},
  url = {https://doi.org/10.1007/s10552-026-02236-y}
}

RIS

TY  - JOUR
TI  - Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment.
AU  - Kheirkhah Rahimabad P
AU  - Sekhon S
AU  - John E
PY  - 2026
JO  - Cancer causes & control : CCC
DO  - 10.1007/s10552-026-02236-y
UR  - https://doi.org/10.1007/s10552-026-02236-y
ER  - 

APA

P, K. R., S, S., & E, J. (2026). Racial and ethnic disparities in enrollment for clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment.. Cancer causes & control : CCC. https://doi.org/10.1007/s10552-026-02236-y

Source records